Recombinant Human Growth Hormone (rHGH) is a 191 amino acid peptide hormone identical in structure to endogenous somatotropin. Produced through recombinant DNA technology to ensure complete sequence fidelity and consistent biological activity. Hudson Science’s 360IU kit supplies ten individually sealed 36IU lyophilized vials, delivering the highest total IU capacity in CSD’s HGH range, designed for extended high volume research programs requiring maximum compound availability across multiple administration timepoints from a single matched batch kit procurement. Current inventory is limited and prioritized allocation is recommended for active research programs requiring consistent compound supply continuity.
The 36IU per vial concentration represents a significantly higher per unit IU loading than the 10IU vials in CSD’s F40 Biotech HGH Kit and standalone HGH presentations. Delivering 3.6 times the compound per vial and supporting research protocols requiring higher per administration IU doses from a single reconstituted vial. At 36IU per vial with ten vials, the kit provides 360IU total. Sufficient for extended research timelines at elevated dose points that would exhaust the F40 Biotech 100IU 10 pack within a fraction of the protocol duration. The individually sealed vial format maintains the critical freshness advantage for rHGH research, each vial reconstituted only when required and used within its approximately 3 day reconstituted stability window, preserving the biological activity of remaining vials in lyophilized form throughout the full kit usage period.
Recombinant HGH delivers the 191 amino acid somatotropin hormone directly into systemic circulation; bypassing pituitary regulation entirely and producing IGF-1 axis stimulation, protein synthesis activity, lipolytic effects, and the full downstream growth hormone signaling cascade independent of endogenous secretory capacity. This direct hormone delivery distinguishes rHGH from every GHRH analogue and GHRP in CSD’s range: Sermorelin, Tesamorelin, CJC-1295, GHRP-2, GHRP-6, Ipamorelin, and Hexarelin all stimulate endogenous pituitary GH secretion through receptor mediated pathways, while rHGH delivers the hormone itself at the researcher’s defined dose independent of the subject’s pituitary responsiveness or endogenous secretory capacity.
Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks rHGH across multiple format and IU concentration options: this Hudson Science 360IU 10 pack, the F40 Biotech 100IU 10 pack, the F40 Biotech standalone 10IU vial, and the GH secretagogue range for researchers examining pituitary stimulating alternatives to direct rHGH administration. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute individual vials with bacteriostatic water prior to use. Store lyophilized vials at 2–8°C away from direct light. Once reconstituted refrigerate and use within 3 days. Intended for research purposes only.
Commonly researched alongside IGF-1 LR3 and GHRH analogue compounds in comparative growth hormone axis and anabolic signaling studies. Browse CSD’s full HGH and peptide range for complete sourcing.
Reviews
There are no reviews yet